{"count": 4, "results": [{"_id": "37507992", "pmid": 37507992, "pmcid": "PMC10376833", "title": "Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia", "journal": "Antioxidants (Basel)", "authors": ["Lopez-Lopez A", "Valenzuela R", "Rodriguez-Perez AI", "Guerra MJ", "Labandeira-Garcia JL", "Muñoz A"], "date": "2023-07-19T00:00:00Z", "doi": "10.3390/antiox12071454", "meta_date_publication": "2023 Jul 19", "meta_volume": "12", "meta_issue": "7", "meta_pages": "", "score": 50238.44, "text_hl": "When @SPECIES_10116 @@@rats@@@ with already established @DISEASE_Dyskinesia_Drug_Induced @DISEASE_MESH:D004409 @@@dyskinesia@@@ were treated with the same dose of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (15 mg/kg, orally) for a period of 10 days, the decrease in @<m>DISEASE_Cerebral_Palsy</m> @DISEASE_MESH:D002547 @@@dyskinetic@@@ behavior was not significant (Figure 4C). ", "citations": {"NLM": "Lopez-Lopez A, Valenzuela R, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL, Muñoz A. Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia Antioxidants (Basel). 2023 Jul 19;12(7):. PMID: 37507992", "BibTeX": "@article{37507992, title={Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia}, author={Lopez-Lopez A and Valenzuela R and Rodriguez-Perez AI and Guerra MJ and Labandeira-Garcia JL and Muñoz A}, journal={Antioxidants (Basel)}, volume={12}, number={7}}"}}, {"_id": "19762786", "pmid": 19762786, "title": "Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts.", "journal": "Arterioscler Thromb Vasc Biol", "authors": ["Yang YJ", "Qian HY", "Huang J", "Li JJ", "Gao RL", "Dou KF", "Yang GS", "Willerson JT", "Geng YJ"], "date": "2009-12-01T00:00:00Z", "doi": "10.1161/ATVBAHA.109.189662", "meta_date_publication": "2009 Dec", "meta_volume": "29", "meta_issue": "12", "meta_pages": "2076-82", "score": 50050.492, "text_hl": "At 6 weeks, MRI showed the number of @<m>DISEASE_Cerebral_Palsy</m> @DISEASE_MESH:D002547 @@@dyskinetic@@@ segments and the @DISEASE_Infarction @DISEASE_MESH:D007238 @@@infarct@@@ size were significantly decreased in the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIMV@@@ group. ", "citations": {"NLM": "Yang YJ, Qian HY, Huang J, Li JJ, Gao RL, Dou KF, Yang GS, Willerson JT, Geng YJ. Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2076-82. PMID: 19762786", "BibTeX": "@article{19762786, title={Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts.}, author={Yang YJ and Qian HY and Huang J and Li JJ and Gao RL and Dou KF and Yang GS and Willerson JT and Geng YJ}, journal={Arterioscler Thromb Vasc Biol}, volume={29}, number={12}, pages={2076-82}}"}}, {"_id": "26779598", "pmid": 26779598, "title": "Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass.", "journal": "Vascul Pharmacol", "authors": ["Ouk T", "Amr G", "Azzaoui R", "Delassus L", "Fossaert E", "Tailleux A", "Bordet R", "Modine T"], "date": "2016-05-01T00:00:00Z", "doi": "10.1016/j.vph.2015.12.005", "meta_date_publication": "2016 May", "meta_volume": "80", "meta_issue": "", "meta_pages": "59-66", "score": 50046.668, "text_hl": "In a @SPECIES_10116 @@@rat@@@ model of CPB, we demonstrated that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ protected against CPB-induced @DISEASE_Vascular_Diseases @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@, @<m>DISEASE_Cerebral_Palsy</m> @DISEASE_MESH:D002547 @@@cerebral and systemic@@@ @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ in parallel to @DISEASE_Memory_Disorders @DISEASE_MESH:D008569 @@@memory impairment@@@ prevention.", "citations": {"NLM": "Ouk T, Amr G, Azzaoui R, Delassus L, Fossaert E, Tailleux A, Bordet R, Modine T. Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass. Vascul Pharmacol. 2016 May;80():59-66. PMID: 26779598", "BibTeX": "@article{26779598, title={Lipid-lowering drugs prevent neurovascular and cognitive consequences of cardiopulmonary bypass.}, author={Ouk T and Amr G and Azzaoui R and Delassus L and Fossaert E and Tailleux A and Bordet R and Modine T}, journal={Vascul Pharmacol}, volume={80}, pages={59-66}}"}}, {"_id": "26535078", "pmid": 26535078, "pmcid": "PMC4624069", "title": "Simvastatin Reduces Lipopolysaccharides-Accelerated Cerebral Ischemic Injury via Inhibition of Nuclear Factor-kappa B Activity", "journal": "Biomol Ther (Seoul)", "authors": ["Anthony Jalin AM", "Lee JC", "Cho GS", "Kim C", "Ju C", "Pahk K", "Song HY", "Kim WK"], "date": "2015-11-01T00:00:00Z", "doi": "10.4062/biomolther.2015.124", "meta_date_publication": "2015 Nov", "meta_volume": "23", "meta_issue": "6", "meta_pages": "531-8", "score": 50046.598, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ was administrated orally 4 times at 72, 48, 25 and 1 h before the induction of the @<m>DISEASE_Cerebral_Palsy</m> @DISEASE_MESH:D002547 @@@cerebral ischemic@@@ insult.", "citations": {"NLM": "Anthony Jalin AM, Lee JC, Cho GS, Kim C, Ju C, Pahk K, Song HY, Kim WK. Simvastatin Reduces Lipopolysaccharides-Accelerated Cerebral Ischemic Injury via Inhibition of Nuclear Factor-kappa B Activity Biomol Ther (Seoul). 2015 Nov;23(6):531-8. PMID: 26535078", "BibTeX": "@article{26535078, title={Simvastatin Reduces Lipopolysaccharides-Accelerated Cerebral Ischemic Injury via Inhibition of Nuclear Factor-kappa B Activity}, author={Anthony Jalin AM and Lee JC and Cho GS and Kim C and Ju C and Pahk K and Song HY and Kim WK}, journal={Biomol Ther (Seoul)}, volume={23}, number={6}, pages={531-8}}"}}]}